SCHEMBL1454366

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL30834280	0.81	ACHE (0.62)	ACHEMAOAMAOBPOLLTDP2
	SCHEMBL7699645	0.81	ACHE (0.62)	ACHEMAOAMAOBPOLLTDP2
	SCHEMBL5952962	0.81	ACHE (0.49)	ACHE
	SCHEMBL5952726	0.79	ACHE (0.59)	ACHEMAOAMAOBTDP2NSD2
	SCHEMBL14521932	0.79	ACHE (0.35)	ACHE
	SCHEMBL5952037	0.78	ACHE (0.36)	ACHEMAOAHSP90AA1
	SCHEMBL5953017	0.78	ACHE (0.50)	ACHEMAOAMAOB
	SCHEMBL3661432	0.77	ACHE (0.49)	ACHEMAOAMAOB
	SCHEMBL6936179	0.74	ACHE (1.00)	ACHEMAOAMAOB
	SCHEMBL30666460	0.74	ACHE (1.00)	ACHEMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.